NivolumabGrade 3 Hepatitis and grade 4 colitis: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-70027-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：366 / 366

相关论文

共 50 条

[21] PseudoephedrineIschaemic colitis: 4 case reports
Reactions Weekly, 1999, 772 (1) : 12 - 12
[22] Ipilimumab/nivolumabRash, colitis and hepatitis: 6 case reports
Reactions Weekly, 2017, 1657 (1) : 250 - 250
[23] Nivolumab/tumour infiltrating lymphocytesGrade 3 and grade 4 fever: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 256 - 256
[24] NivolumabGrade 3 diarrhoea: case report
Reactions Weekly, 2017, 1658 (1) : 350 - 350
[25] IpilimumabAutoimmune colitis: 3 case reports
Reactions Weekly, 2016, 1616 (1) : 85 - 85
[26] LansoprazoleMicroscopic colitis: 3 case reports
Reactions Weekly, 2006, 1093 (1) : 21 - 22
[27] IpilimumabPerforating colitis: 3 case reports
Reactions Weekly, 2013, 1476 (1) : 21 - 21
[28] IpilimumabAutoimmune colitis: 3 case reports
Reactions Weekly, 2015, 1539 (1) : 177 - 177
[29] Alectinib/ceritinib/etoposideLack of efficacy, toxicemia and grade-3 hepatitis: 3 case reports
Reactions Weekly, 2022, 1930 (1) : 24 - 24
[30] CyclophosphamideGrade 3−4 neutropenia and grade 3 infection: 8 case reports
Reactions Weekly, 2016, 1620 (1) : 60 - 60

← 1 2 3 4 5 →